Navigation Links
NicOx' Naproxcinod ABPM Data Presented at American Heart Association
Date:11/7/2007

hieve statistical significance for DBP (p=0.007).

Blood pressure data were collected in the first phase 3 trial for naproxcinod (the 301 study) using Office Blood Pressure Measurements (OBPM) up to 13 weeks (see NOTE 2). The top-line results of this trial revealed a sustained reduction in blood pressure for naproxcinod, compared to baseline and naproxen. Additional results from this phase 3 trial are due to be presented on November 10, 2007, at the 71st annual meeting of the American College of Rheumatology.

"This ABPM trial was the first clinical study focusing specifically on naproxcinod's 24-hour blood pressure profile and its results reveal a clear difference compared to naproxen, which is one of the best-known cardiovascular NSAIDs," said Raymond Townsend, Professor of Medicine at the University of Pennsylvania, Philadelphia, who advised NicOx on the ABPM study. "The medical community recognizes the importance of blood pressure control in reducing the rate of serious cardiovascular events in elderly patients. These data add to the promising blood pressure results obtained by OBPM in the first 13-week phase 3 study and, if supported by the results of the ongoing 302 and 303 phase 3 studies, should contribute to naproxcinod becoming a valuable alternative to selective and non-selective NSAIDs for treating the signs and symptoms of osteoarthritis."

The presentation showed naproxcinod was well tolerated during the study. The number of subjects with at least one treatment related adverse event was low and evenly spread between naproxcinod and naproxen. There were no adverse events suggesting clinically significant hypotensive effects in either group.

Details of study design and ABPM monitoring

The trial was an 8-week, double-blind, randomized, cross-over study in which 131 male and female healthy volunteers were enrolled at 15 US clinical sites to receive either naproxcinod 750 mg bid, followed by naproxen 500 mg bid for 2 weeks, or the
'/>"/>

SOURCE NicOx S.A.
Copyright©2007 PR Newswire.
All rights reserved

3

GOOD

Page: 1 2 3 4

Related medicine technology :

1. NicOx Reports TOPIGEN to Advance TPI-1020 Into Phase 2 for COPD Following Promising Clinical Results
2. NicOx and Ferrer Present Promising Clinical and Preclinical Results in Dermatology
3. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
4. Pre-clinical Data on Recent Advances with HIV VLP Vaccine Presented at AIDS Vaccine 07 Conference
5. New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia
6. Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology
7. Ozarelix Phase 2 Data Presented at 29th Congress of the Societe Internationale dUrologie
8. GeoVax Successful HIV/AIDS Vaccine Trial Data Presented at AIDS Vaccine 2007 Conference
9. Study Results for Aclidinium Bromide, a Novel Anticholinergic, Presented at European Respiratory Society Annual Congress
10. Promising Data from Paratek Pharmaceuticals MAR Inhibitor Program Presented in Late Breaker Session at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
11. New Phase III Data Presented for Once Monthly Dosing Regimen of Risedronate to Treat Postmenopausal Osteoporosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... , May 24, 2013 In accordance with ... and Rule 14e-1 of the United States Exchange Act, Echo ... original offer for Elan Corporation (NYSE: ELN). Background ... ("Royalty Pharma") made an offer for the entire of the ... plc ("Elan") (the "Original Offer").  On 20 ...
(Date:5/23/2013)... , May 24, 2013 3SBio Inc. ... "Company"), a leading China -based ... marketing biopharmaceutical products, announced today that, at an ... Company,s shareholders voted in favor of the proposal ... and plan of merger dated February 8, 2013, ...
(Date:5/23/2013)... , May 23, 2013 Amgen (NASDAQ: ... th Annual  Healthcare Conference on Thursday, May 30, 2013, ... , beginning at 9:20 a.m. Eastern Daylight Time. ... Amgen, will present at the conference. Live audio of the ... website, www.amgen.com , under Investors. A replay of the ...
Breaking Medicine Technology:Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 2Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 3Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 4Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 5Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 6Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 7Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 8Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 93SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 23SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 3
... emerging biotech,company focused on developing novel therapeutics for ... Drug designation from the,U.S. Food and Drug Administration ... hypophosphatasia, a rare, life-threatening,genetic bone disease. In August ... I clinical trial of ENB-0040., "ENB-0040 represents ...
... ROCKVILLE, Md., Sept. 19 Novavax, Inc.,(Nasdaq: NVAX ... Singhvi, President and Chief Executive Officer, will be presenting ... York, NY. The,conference is being held September 22-25, 2008 ... Thursday, September 25, 2008 at 10:30 am.,Eastern Time. Dr. ...
Cached Medicine Technology:Enobia Pharma Receives FDA Orphan Drug Designation for Hypophosphatasia Product Candidate ENB-0040 2Enobia Pharma Receives FDA Orphan Drug Designation for Hypophosphatasia Product Candidate ENB-0040 3
(Date:5/25/2013)... Beach, California (PRWEB) May 25, 2013 ... respectfully honoring those who have died serving our Country, ... work with prolonged partying and recklessness. The DUI attorneys ... Day Weekend DUI checklist to help keep this weekend’s ... Traffic Records System , there were more than 950 ...
(Date:5/25/2013)... An experienced Chandler dentist has just launched a ... Surge, LLC. , http://www.ChandlerDentalExcellence.com/Teeth-Whitening.php , Several ... the treatment, can be performed in the office or ... will be chosen for the individual patient. , In-office ... peroxide-based whitening gel is used along with a whitening ...
(Date:5/25/2013)... Idaho (PRWEB) May 25, 2013 A ... prevalent type of peripheral neuropathy. According to neuropathy expert ... , it is estimated that the disorder affects almost ... common complication arising from Diabetes. The high blood sugar ... Diabetes and patients suffering from it usually tend to ...
(Date:5/25/2013)... (HealthDay News) -- Animals make great companions for senior citizens, ... the car are far more likely to crash than those ... The new study included 2,000 licensed drivers aged 70 and ... how often they drove with their pet in the car. ... crash risk was twice as high as among those who ...
(Date:5/25/2013)... (PRWEB) May 25, 2013 Studies from ... who are carrying excessive weight and their inability to ... many, simply losing weight can naturally relieve many symptoms. ... that improvement in sleep quality was significantly associated with ... month study dated November 6th, 2012, researchers ...
Breaking Medicine News(10 mins):Health News:Criminal Attorneys Provide Memorial Day Weekend DUI Checklist and Safety Information 2Health News:Criminal Attorneys Provide Memorial Day Weekend DUI Checklist and Safety Information 3Health News:Chandler Dentist Launches Teeth Whitening Service Page on Website in Partnership with JD Media Surge, LLC 2Health News:Diabetic Neuropathy treatment hits new grounds- Neuracel launches the complete natural treatment 2Health News:Seniors More Likely to Crash When Driving With Pet: Study 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Offers Newly Improved hCG Diet Plans Capable of Delivering Better Sleep 2
... Kapil Sibal Friday unveiled two test kits that can ... ,The kits, developed by the International Centre ... designed synthetic antigens and can accurately detect the diseases. ... produce a visually readable signal that makes it easy ...
... Children with learning disabilities are vulnerable to sexual abuse and ... protect themselves.// ,In a recent court case ... special needs teacher, it was obvious that both the victim ... relate the alleged incident in an accurate manner. ...
... Just about every adult these days knows that a diet ... regular exercise and risky behaviors like smoking is a recipe ... renowned heart disease researcher says adults need to realize that ... their own problems years down the road. ...
... Government officials are worried about the lack of natural B ... ,Previous research has linked the inadequacy of this vitamin ... had also led to breads and cereals being supplemented with ... ,A nation-wide study, undertaken between 1999 and 2004 ...
... Institute of Health Research, in collaboration with Heart and ... women react// differently to medications for their heart disease. ... Canadian GENESIS project, men's ailing hearts respond differently to ... which are usually effective in pinpointing heart problems in ...
... simple ways to improve your heart health? Including a handful ... your day, may be one easy and// satisfying way. Over ... show why including a handful of almonds can help you ... what they are finding. ,Almonds are high in ...
Cached Medicine News:Health News:Special Children Need to Be Taught Sexual Safety 2Health News:Special Children Need to Be Taught Sexual Safety 3Health News:Cure for Most Heart Attacks Is Free, but It's Important to Start Young 2Health News:Cure for Most Heart Attacks Is Free, but It's Important to Start Young 3Health News:Be True to Your Heart With a Handful of Almonds 2Health News:Be True to Your Heart With a Handful of Almonds 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: